Market Overview

Sangamo BioSciences, Inc. Reports Q4 EPS of $(0.07); Revenue of $8.90M vs $4.70M Est

Related Articles (SGMO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional